Masimo (NASDAQ: MASI) announced today that a new consensus statement on postoperative anemia management was published in Anaesthesia by an international panel of clinicians specializing in patient blood management, which includes clear guidance on the use and benefits of noninvasive hemoglobin measurement.[1] The statement, which discusses both spot-check and continuous measurement, references the Masimo Rad-67™ Pulse CO-Oximeter®, a spot-check device that measures noninvasive hemoglobin usin...